Profile - To The Moon

Adrian88

Shoot for the stars!

Posts · 194Posts · 194
Following · 0Following · 0
Followers · 0Followers · 0

- Adrian88Adrian88
  ·2021-09-23
  Read
  Private Equity Party Is Ending and We’re Exhausted, Carlyle Says
  (Bloomberg) --The private equity dealmaking boom is peaking after a frenetic year that’s left the in
  Private Equity Party Is Ending and We’re Exhausted, Carlyle Says
  191 3
  5
  Share
  Report
- Adrian88Adrian88
  ·2021-09-22
  Like
  Sorry, this post has been deleted
  217 Comment
  2
  Share
  Report
- Adrian88Adrian88
  ·2021-09-21
  Go go go
  Sorry, this post has been deleted
  509 1
  3
  Share
  Report
- Adrian88Adrian88
  ·2021-09-20
  Good
  Sorry, this post has been deleted
  168 1
  3
  Share
  Report
- Adrian88Adrian88
  ·2021-09-19
  Read
  Pfizer Covid-19 shot's protection against hospitalisation wanes in study
  WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation af
  Pfizer Covid-19 shot's protection against hospitalisation wanes in study
  197 1
  4
  Share
  Report
- Adrian88Adrian88
  ·2021-09-18
  Read
  Pfizer Covid-19 shot's protection against hospitalisation wanes in study
  WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation af
  Pfizer Covid-19 shot's protection against hospitalisation wanes in study
  335 1
  5
  Share
  Report
- Adrian88Adrian88
  ·2021-09-17
  Good read
  S&P ends modestly lower as rising Treasury yields offset robust retail data
  NEW YORK (Reuters) - The S&P 500 ended slightly down on Thursday, paring losses in late trading afte
  S&P ends modestly lower as rising Treasury yields offset robust retail data
  236 2
  4
  Share
  Report
- Adrian88Adrian88
  ·2021-09-16
  Liked
  Sorry, this post has been deleted
  238 Comment
  3
  Share
  Report
- Adrian88Adrian88
  ·2021-09-15
  Love it
  Sorry, this post has been deleted
  230 Comment
  1
  Share
  Report
- Adrian88Adrian88
  ·2021-09-13
  Good
  Sorry, this post has been deleted
  231 2
  4
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4089878444731060","uuid":"4089878444731060","gmtCreate":1626776047519,"gmtModify":1626920100355,"name":"Adrian88","pinyin":"adrian88","introduction":"","introductionEn":null,"signature":"Shoot for the stars!","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":20,"headSize":382,"tweetSize":194,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":863625005,"gmtCreate":1632388479007,"gmtModify":1676530770053,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089878444731060","authorIdStr":"4089878444731060"},"themes":[],"htmlText":"Read&nbsp;","listText":"Read&nbsp;","text":"Read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/863625005","repostId":"2169616196","repostType":4,"repost":{"id":"2169616196","pubTimestamp":1632387858,"share":"https://ttm.financial/m/news/2169616196?lang=&edition=fundamental","pubTime":"2021-09-23 17:04","market":"us","language":"en","title":"Private Equity Party Is Ending and We’re Exhausted, Carlyle Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2169616196","media":"Bloomberg","summary":"(Bloomberg) --The private equity dealmaking boom is peaking after a frenetic year that’s left the in","content":"<p>(Bloomberg) --The private equity dealmaking boom is peaking after a frenetic year that’s left the industry exhausted.</p>\n<p>That’s the view of Carlyle Group Inc.’s co-head of European buyouts Marco De Benedetti, who says firms have probably finished the catch-up necessary after last year’s hiatus. The trend of doing deals faster will likely remain though, which means managers need to permanently adjust how they conduct due diligence, he told the SuperInvestor forum in London on Wednesday.</p>\n<p>“We are peak in the terms of deal activity,” De Benedetti said, adding that the ramping up of capital deployment and fund raising cycles would also likely remain. “Speed is here to stay,” he said.</p>\n<p>The news may be welcomed by executives tired from frantic scrambles to respond to deal opportunities while rushing due diligence and other checks in half the time usually allotted. The pace was so intense that Carlyle made staff take mandatory time off to recharge, De Benedetti said.</p>\n<p>Companies will need to restructure themselves so they can screen opportunities ahead of time and respond faster to proposals with smarter use of data analysis. That will favor bigger managers with more resources, said De Benedetti.</p>\n<p>“Today, if you start looking at an asset when the formal process starts, you are going to lose,” he told the audience.</p>\n<p></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Private Equity Party Is Ending and We’re Exhausted, Carlyle Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPrivate Equity Party Is Ending and We’re Exhausted, Carlyle Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 17:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/private-equity-boss-says-party-080418182.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) --The private equity dealmaking boom is peaking after a frenetic year that’s left the industry exhausted.\nThat’s the view of Carlyle Group Inc.’s co-head of European buyouts Marco De ...</p>\n\n<a href=\"https://finance.yahoo.com/news/private-equity-boss-says-party-080418182.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CG":"凯雷","EQR":"资产住宅公司"},"source_url":"https://finance.yahoo.com/news/private-equity-boss-says-party-080418182.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2169616196","content_text":"(Bloomberg) --The private equity dealmaking boom is peaking after a frenetic year that’s left the industry exhausted.\nThat’s the view of Carlyle Group Inc.’s co-head of European buyouts Marco De Benedetti, who says firms have probably finished the catch-up necessary after last year’s hiatus. The trend of doing deals faster will likely remain though, which means managers need to permanently adjust how they conduct due diligence, he told the SuperInvestor forum in London on Wednesday.\n“We are peak in the terms of deal activity,” De Benedetti said, adding that the ramping up of capital deployment and fund raising cycles would also likely remain. “Speed is here to stay,” he said.\nThe news may be welcomed by executives tired from frantic scrambles to respond to deal opportunities while rushing due diligence and other checks in half the time usually allotted. The pace was so intense that Carlyle made staff take mandatory time off to recharge, De Benedetti said.\nCompanies will need to restructure themselves so they can screen opportunities ahead of time and respond faster to proposals with smarter use of data analysis. That will favor bigger managers with more resources, said De Benedetti.\n“Today, if you start looking at an asset when the formal process starts, you are going to lose,” he told the audience.","news_type":1},"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869220303,"gmtCreate":1632294988502,"gmtModify":1676530745264,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089878444731060","authorIdStr":"4089878444731060"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869220303","repostId":"1171172048","repostType":4,"isVote":1,"tweetType":1,"viewCount":217,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860523322,"gmtCreate":1632189748866,"gmtModify":1676530721467,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089878444731060","authorIdStr":"4089878444731060"},"themes":[],"htmlText":"Go go go&nbsp;","listText":"Go go go&nbsp;","text":"Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860523322","repostId":"1163068688","repostType":4,"isVote":1,"tweetType":1,"viewCount":509,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887721585,"gmtCreate":1632101241847,"gmtModify":1676530700469,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089878444731060","authorIdStr":"4089878444731060"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/887721585","repostId":"1183393342","repostType":4,"isVote":1,"tweetType":1,"viewCount":168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887827130,"gmtCreate":1632019508020,"gmtModify":1676530687537,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089878444731060","authorIdStr":"4089878444731060"},"themes":[],"htmlText":"Read","listText":"Read","text":"Read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/887827130","repostId":"2168574191","repostType":4,"repost":{"id":"2168574191","pubTimestamp":1631928823,"share":"https://ttm.financial/m/news/2168574191?lang=&edition=fundamental","pubTime":"2021-09-18 09:33","market":"us","language":"en","title":"Pfizer Covid-19 shot's protection against hospitalisation wanes in study","url":"https://stock-news.laohu8.com/highlight/detail?id=2168574191","media":"The Straits Times","summary":"WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation af","content":"<div>\n<p>WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from ...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Covid-19 shot's protection against hospitalisation wanes in study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Covid-19 shot's protection against hospitalisation wanes in study\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-18 09:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from ...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168574191","content_text":"WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from 21 US hospitals across 18 states.\nTwo doses of either vaccine provided more protection against hospitalisation than the one-dose Johnson & Johnson vaccine, the study found, though Pfizer's advantage over J&J narrowed over time, according to the study published on Friday (Sept 17) by the Centres for Disease Control and Prevention with collaborators across the country.\nAll three vaccines provided substantial protection after four months - Moderna's was 92 per cent effective against hospitalisation by then, with Pfizer's at 77 per cent and J&J at 68 per cent.\nThe data, published on Friday, may influence the debate over whether Americans should receive a third dose of vaccine to ward off the virus.\nAdvisers to the Food and Drug Administration are expected to vote on Friday on whether to recommend a booster shot, and they've mostly had to rely on data from Israel and the UK on whether the shots' effectiveness wanes over time.\nThe US is facing a surge of Covid-19 infections fuelled by the highly transmissible Delta variant, particularly among unvaccinated parts of the country, and breakthrough infections among vaccinated people have become more common.\nThe CDC study looked at 3,689 non-immunocompromised adults from March to August. The researchers noted that the vaccine effectiveness differences between Moderna and Pfizer's shots, which both use a mechanism called messenger RNA, could be due to differences in timings between doses.\nThe second dose of the Pfizer vaccine is typically delivered after three weeks, while Moderna patients wait four weeks.\nThey also noted several limitations to the study, including the fact that a relatively small number of patients had received the J&J vaccine compared with the mRNA vaccines.\nPrevious studies have found that Moderna's vaccine appears to generate more antibodies than Pfizer's, though it's not clear if antibodies are even the most important component in immunity over the long term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884731782,"gmtCreate":1631932360346,"gmtModify":1676530672618,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089878444731060","authorIdStr":"4089878444731060"},"themes":[],"htmlText":"Read","listText":"Read","text":"Read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/884731782","repostId":"2168574191","repostType":4,"repost":{"id":"2168574191","pubTimestamp":1631928823,"share":"https://ttm.financial/m/news/2168574191?lang=&edition=fundamental","pubTime":"2021-09-18 09:33","market":"us","language":"en","title":"Pfizer Covid-19 shot's protection against hospitalisation wanes in study","url":"https://stock-news.laohu8.com/highlight/detail?id=2168574191","media":"The Straits Times","summary":"WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation af","content":"<div>\n<p>WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from ...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Covid-19 shot's protection against hospitalisation wanes in study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Covid-19 shot's protection against hospitalisation wanes in study\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-18 09:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from ...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168574191","content_text":"WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from 21 US hospitals across 18 states.\nTwo doses of either vaccine provided more protection against hospitalisation than the one-dose Johnson & Johnson vaccine, the study found, though Pfizer's advantage over J&J narrowed over time, according to the study published on Friday (Sept 17) by the Centres for Disease Control and Prevention with collaborators across the country.\nAll three vaccines provided substantial protection after four months - Moderna's was 92 per cent effective against hospitalisation by then, with Pfizer's at 77 per cent and J&J at 68 per cent.\nThe data, published on Friday, may influence the debate over whether Americans should receive a third dose of vaccine to ward off the virus.\nAdvisers to the Food and Drug Administration are expected to vote on Friday on whether to recommend a booster shot, and they've mostly had to rely on data from Israel and the UK on whether the shots' effectiveness wanes over time.\nThe US is facing a surge of Covid-19 infections fuelled by the highly transmissible Delta variant, particularly among unvaccinated parts of the country, and breakthrough infections among vaccinated people have become more common.\nThe CDC study looked at 3,689 non-immunocompromised adults from March to August. The researchers noted that the vaccine effectiveness differences between Moderna and Pfizer's shots, which both use a mechanism called messenger RNA, could be due to differences in timings between doses.\nThe second dose of the Pfizer vaccine is typically delivered after three weeks, while Moderna patients wait four weeks.\nThey also noted several limitations to the study, including the fact that a relatively small number of patients had received the J&J vaccine compared with the mRNA vaccines.\nPrevious studies have found that Moderna's vaccine appears to generate more antibodies than Pfizer's, though it's not clear if antibodies are even the most important component in immunity over the long term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884982652,"gmtCreate":1631846459776,"gmtModify":1676530651451,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089878444731060","authorIdStr":"4089878444731060"},"themes":[],"htmlText":"Good read","listText":"Good read","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/884982652","repostId":"1105376345","repostType":4,"repost":{"id":"1105376345","pubTimestamp":1631833833,"share":"https://ttm.financial/m/news/1105376345?lang=&edition=fundamental","pubTime":"2021-09-17 07:10","market":"us","language":"en","title":"S&P ends modestly lower as rising Treasury yields offset robust retail data","url":"https://stock-news.laohu8.com/highlight/detail?id=1105376345","media":"Reuters","summary":"NEW YORK (Reuters) - The S&P 500 ended slightly down on Thursday, paring losses in late trading afte","content":"<p>NEW YORK (Reuters) - The S&amp;P 500 ended slightly down on Thursday, paring losses in late trading after unexpectedly strong retail sales data underscored the strength of the U.S. economic recovery.</p>\n<p>The three major indexes spent much of the day in negative territory as rising U.S. Treasury yields pressured market-leading tech stocks, and the rising dollar weighed on exporters.</p>\n<p>Amazon.com Inc, buoyed by solid online sales in the Commerce Department’s report, helped push the Nasdaq into positive territory.</p>\n<p>“Looking at today, clearly we had positive news from retail sales and it looks as if the massive slowdown in the economy is not materializing as a lot of people expected,” said Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina.</p>\n<p>“It’s a nice reminder that the economy is still taking two steps forward for each step back even amid the COVID concerns,” Detrick added.</p>\n<p>Economically sensitive transports and microchips were among the outperformers.</p>\n<p>Data released before the opening bell showed an unexpected bump in retail sales as shoppers weathered Hurricane Ida and the COVID Delta variant, evidence of resilience in the consumer, who contributes about 70% to U.S. economic growth.</p>\n<p>“Once again, it shows the U.S. consumer continues to spend and continues to help this economy grow,” Detrick said.</p>\n<p>The Dow Jones Industrial Average fell 63.07 points, or 0.18%, to 34,751.32; the S&amp;P 500 lost 6.95 points, or 0.16%, at 4,473.75; and the Nasdaq Composite added 20.40 points, or 0.13%, at 15,181.92.</p>\n<p>Eight of the 11 major sectors in the S&amp;P 500 ended lower, with materials suffering the largest percentage drop.</p>\n<p>The consumer discretionary spending sector posted the biggest gain, with Amazon.com doing the heavy lifting.</p>\n<p>Apparel company Gap Inc gained 1.6%. Online marketplace Etsy Inc and luxury accessory company Tapestry Inc rose 3.1% and 1.9%, respectively.</p>\n<p>Ford Motor Co rose 1.4% after it announced plans to boost production of its F-150 electric pickup model.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.27-to-1 ratio; on Nasdaq, a 1.06-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted nine new 52-week highs and one new low; the Nasdaq Composite recorded 82 new highs and 94 new lows.</p>\n<p>Volume on U.S. exchanges was 9.37 billion shares, compared with the 9.44 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ends modestly lower as rising Treasury yields offset robust retail data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ends modestly lower as rising Treasury yields offset robust retail data\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/usa-stocks/us-stocks-sp-ends-modestly-lower-as-rising-treasury-yields-offset-robust-retail-data-idUSL1N2QI2MB><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (Reuters) - The S&P 500 ended slightly down on Thursday, paring losses in late trading after unexpectedly strong retail sales data underscored the strength of the U.S. economic recovery.\nThe ...</p>\n\n<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-sp-ends-modestly-lower-as-rising-treasury-yields-offset-robust-retail-data-idUSL1N2QI2MB\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-sp-ends-modestly-lower-as-rising-treasury-yields-offset-robust-retail-data-idUSL1N2QI2MB","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105376345","content_text":"NEW YORK (Reuters) - The S&P 500 ended slightly down on Thursday, paring losses in late trading after unexpectedly strong retail sales data underscored the strength of the U.S. economic recovery.\nThe three major indexes spent much of the day in negative territory as rising U.S. Treasury yields pressured market-leading tech stocks, and the rising dollar weighed on exporters.\nAmazon.com Inc, buoyed by solid online sales in the Commerce Department’s report, helped push the Nasdaq into positive territory.\n“Looking at today, clearly we had positive news from retail sales and it looks as if the massive slowdown in the economy is not materializing as a lot of people expected,” said Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina.\n“It’s a nice reminder that the economy is still taking two steps forward for each step back even amid the COVID concerns,” Detrick added.\nEconomically sensitive transports and microchips were among the outperformers.\nData released before the opening bell showed an unexpected bump in retail sales as shoppers weathered Hurricane Ida and the COVID Delta variant, evidence of resilience in the consumer, who contributes about 70% to U.S. economic growth.\n“Once again, it shows the U.S. consumer continues to spend and continues to help this economy grow,” Detrick said.\nThe Dow Jones Industrial Average fell 63.07 points, or 0.18%, to 34,751.32; the S&P 500 lost 6.95 points, or 0.16%, at 4,473.75; and the Nasdaq Composite added 20.40 points, or 0.13%, at 15,181.92.\nEight of the 11 major sectors in the S&P 500 ended lower, with materials suffering the largest percentage drop.\nThe consumer discretionary spending sector posted the biggest gain, with Amazon.com doing the heavy lifting.\nApparel company Gap Inc gained 1.6%. Online marketplace Etsy Inc and luxury accessory company Tapestry Inc rose 3.1% and 1.9%, respectively.\nFord Motor Co rose 1.4% after it announced plans to boost production of its F-150 electric pickup model.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.27-to-1 ratio; on Nasdaq, a 1.06-to-1 ratio favored advancers.\nThe S&P 500 posted nine new 52-week highs and one new low; the Nasdaq Composite recorded 82 new highs and 94 new lows.\nVolume on U.S. exchanges was 9.37 billion shares, compared with the 9.44 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":236,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885405140,"gmtCreate":1631807541580,"gmtModify":1676530642528,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089878444731060","authorIdStr":"4089878444731060"},"themes":[],"htmlText":"Liked&nbsp;","listText":"Liked&nbsp;","text":"Liked","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/885405140","repostId":"2167651799","repostType":4,"isVote":1,"tweetType":1,"viewCount":238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882633239,"gmtCreate":1631681956121,"gmtModify":1676530607902,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089878444731060","authorIdStr":"4089878444731060"},"themes":[],"htmlText":"Love it","listText":"Love it","text":"Love it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882633239","repostId":"1126583585","repostType":4,"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888423488,"gmtCreate":1631520621344,"gmtModify":1676530564450,"author":{"id":"4089878444731060","authorId":"4089878444731060","name":"Adrian88","avatar":"https://static.tigerbbs.com/e6c821844139b158ef20aa398c55abd1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089878444731060","authorIdStr":"4089878444731060"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/888423488","repostId":"1122970236","repostType":4,"isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}